Revolutionary Facial Rejuvenation
Facial Rejuve is delighted to offer Sculptra, an advanced treatment designed to stimulate collagen production and restore facial volume, resulting in a more youthful and natural appearance. Sculptra delivers gradual improvements over time, making it a preferred choice for individuals seeking long-lasting facial rejuvenation.
What is Sculptra?
Sculptra is an FDA-approved injectable treatment utilizing poly-L-lactic acid (PLLA) to boost the body’s natural collagen production. Unlike traditional fillers that provide immediate results, Sculptra works gradually by rebuilding collagen over several months. This process restores facial volume and improves skin texture, resulting in a rejuvenated look that can last up to two years.
How Does It Work?
Sculptra stimulates collagen production through the following mechanisms:
Key Features and Benefits
What Can Sculptra Treat?
Sculptra effectively addresses a range of facial concerns including:
The Procedure
During your Sculptra treatment session, our skilled practitioners will strategically inject the PLLA formulation into targeted areas of your face. The procedure typically takes 30-60 minutes, and a topical numbing cream may be applied beforehand for your comfort.
Post-Treatment Care
After treatment, you may experience mild swelling, redness, or bruising at the injection sites, which usually resolve within a few days. Properly massaging the treated areas as instructed helps ensure even distribution of the product. It’s advisable to avoid strenuous activities, extreme temperatures, and direct sun exposure for the first 24 hours post-treatment.
Results and Follow-Up
Initial improvements may be visible within weeks, with optimal results manifesting over several months as collagen continues to enhance facial volume and texture. A treatment regimen typically involves three sessions spaced 4-6 weeks apart. Regular follow-up appointments are recommended to maintain your rejuvenated appearance, ensuring ongoing satisfaction with your revitalized look.